Delatestryl is a testosterone injection that is well-known to thicken the blood, which can increase the risk of a blood clot. Recent studies indicate that testosterone replacement therapy may also increase your risk of heart attack, stroke, and death by 30% — especially for older men who are just starting treatment.
UPDATE: Canadian Lawyers file Delatestryl Class Action Lawsuit
July 25, 2014 — Attorneys in Canada have filed a Delatestryl class action against AbbVie, seeking recovery on behalf of Canadians who purchased testosterone products. Click here to read more.
Is there a Delatestryl Class Action Lawsuit?
There is no Delatestryl class action lawsuit for men who were severely injured. However, dozens of lawsuits have been filed by men who were injured by testosterone replacement therapy. These lawsuits are not part of a class action — they are individual legal claims filed by men who have hired their own attorney.